<乌鸦传媒>When Is ADT Right for Biochemically Recurrent Prostate Cancer? Study findings suggest early initiation may not "meaningfully" improve survival outcomes Aug 09, 2021
<乌鸦传媒>Support for MRI-Targeted Biopsy in Prostate Cancer Screening Large Swedish study showed the approach cut overdiagnosis, unnecessary biopsies Jul 09, 2021
<乌鸦传媒>Could Docetaxel Have Role in Unfavorable-Risk Prostate Cancer? Use of chemo reduced radiation-induced cancers, and may prolong OS in low-PSA subgroup Jul 07, 2021
<乌鸦传媒>Do 'Robots' Offer Any Clear Surgical Advantage? Review says no, and Vinay Prasad believes it's a sobering reflection on medical technology Jun 28, 2021 video
<乌鸦传媒>AI for Radiation Therapy Works, but Is it Fully Trusted? Most machine learning-generated plans selected over human plans in head-to-head comparison Jun 16, 2021
<乌鸦传媒>What's Guiding Prostate Cancer Care for Gay Men? Research specific to this group has only scratched the surface Jun 16, 2021
<乌鸦传媒>COVID Vaccine Protection; 'Until You Die From the Cancer'; What's Palliative Care? News, features, and commentary about cancer-related issues Jun 10, 2021
<乌鸦传媒>New Standard for Metastatic Castration-Sensitive Prostate Cancer? Triplet regimen reduced the risk for radiographic progression or death, but OS data await Jun 09, 2021
<乌鸦传媒>BPAs Cut Fracture Risk in Metastatic Prostate Cancer Those receiving enzalutamide with and without radium-223 saw benefits in updated safety analysis Jun 08, 2021
<乌鸦传媒>Radioligand Therapy Boosts Survival in Metastatic CRPC PSMA-directed agent improved overall survival by median 4 months Jun 04, 2021
<乌鸦传媒>With Supplements, ADT in Prostate Cancer of Little Threat to Bone Density Study suggests calcium/vitamin D alone sufficient for long-duration therapy Jun 03, 2021
<乌鸦传媒>Vaccination, Screening Succeeds in Cervical and Prostate Cancers Cervical cancer rates on the decline; PSA testing benefits younger Black men May 19, 2021
<乌鸦传媒>SBRT Safe for Cancer Patients With Multiple Metastases Late adverse events in phase I trial indicate need for extended follow-up May 03, 2021
<乌鸦传媒>Treatment Type a Non-Factor in Prostate Cancer Patients' Anxiety Researchers emphasized importance of psychological interventions as problems arise Apr 29, 2021
<乌鸦传媒>Late ADT a Problem in Prostate Cancer Late dosing of LHRH agonists happens too frequently, researchers report Apr 22, 2021
<乌鸦传媒>No More Men Need to Die From Transrectal Prostate Biopsies A movement toward transperineal biopsies Apr 21, 2021
<乌鸦传媒>More Benefit With Taxane for Aggressive Metastatic Prostate Cancer Higher clinical benefit rate with front-line cabazitaxel versus androgen receptor inhibitor Apr 12, 2021
<乌鸦传媒>Mixed Results for Immunotherapy in Metastatic Prostate Cancer Combination trial missed response endpoint but exceeded historical results Apr 11, 2021
<乌鸦传媒>CCR Score Could Offer ADT-Free Path in Higher-Risk Prostate Cancer Large proportion of intermediate- to high-risk patients could avoid aggressive therapy Feb 12, 2021
<乌鸦传媒>Radionuclide Tx Wins in Third-Line Metastatic CRPC Early trial shows improved PFS, response rates versus cabazitaxel Feb 11, 2021
<乌鸦传媒>Hit and Miss in Castration-Resistant Prostate Cancer No OS benefit with apalutamide-abiraterone, despite improved PFS Feb 11, 2021
<乌鸦传媒>Brain Tumor Risk Upped With Synthetic Progestogen Absolute risk still low, however, and product not currently approved in U.S. Feb 03, 2021
<乌鸦传媒>Whole-Pelvis Tops Prostate-Only RT in High-Risk Disease Practice impact may hinge on knowledge versus clinical bias Jan 28, 2021
<乌鸦传媒>Is This Really Cancer? Movement builds to classify Gleason 6 prostate lesions as nonmalignant Jan 09, 2021
<乌鸦传媒>PARP Inhibitors Linked With Blood Cancer Risk Incidence of MDS/AML under 1%, but further investigation warranted as indications broaden Dec 28, 2020
<乌鸦传媒>High-Risk Prostate Cancer Patients Can Wait 6 Months for Surgery: Study Can be considered low priority procedure during COVID-19 pandemic, researchers say Dec 08, 2020
<乌鸦传媒>FDA OKs 'Game Changer' Radiotracer for Prostate Cancer PET imaging drug detected metastasis at initial diagnosis, outperformed standard for PSA recurrence Dec 01, 2020
<乌鸦传媒>Al Roker's Prostate Cancer Morning show stalwart's diagnosis highlights discrepancies for Black men Nov 10, 2020
<乌鸦传媒>Focal RT Boost in High-Risk Prostate Cancer Cuts PSA Relapse Rates of biochemical relapse cut in half with boost to 95 Gy Oct 29, 2020
<乌鸦传媒>COVID-19 in Health Workers; Stimulating New White Blood Cells: It's TTHealthWatch! This week's topics also include gene expression and COVID infection, and outbreaks in childcare settings Sep 19, 2020 podcast
<乌鸦传媒>Surgery Rates Doubled for High-Risk Prostate Cancer Use of prostatectomy nearly equaled radiotherapy in 2016 Aug 31, 2020
<乌鸦传媒>Lower COVID-19 Risk With ADT for Prostate Cancer Higher risk of infection, more severe disease in men who did not receive hormones Aug 14, 2020
<乌鸦传媒>The Serious Conversation: Delivering Bad News by Telemedicine As office visits move online, clinicians discuss breaking life-changing diagnoses virtually Jul 13, 2020
<乌鸦传媒>Oral ADT Slashes Heart Risk in Advanced Prostate Cancer Novel GnRH antagonist has potential to be new standard, says researcher May 30, 2020
<乌鸦传媒>Studies Make Case for Hormonal Therapy in nmCRPC Prolonged survival with three different androgen signaling inhibitors May 30, 2020
<乌鸦传媒>HCQ Linked to Harm in Cancer Patients Combination with azithromycin associated with three-fold risk of mortality, registry study shows May 28, 2020
<乌鸦传媒>BMI, Weight Change Linked to Prostate Ca Outcomes Gain or loss of body weight both show risk May 07, 2020
<乌鸦传媒>DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
<乌鸦传媒>Bell Ringing Not So Joyous for Cancer Patients? Greater treatment-related distress for those who rang bell at end of treatment Feb 10, 2020
